Efficacy of amblyopia therapy initiated after 9 years of age

Eye

Volumn 18, Issue 6, 2004, Pages 571-574

  Park, K H ^a   Hwang, J M ^a   Ahn, J K ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

9 years or older; Amblyopia; Efficacy; Occlusion

Indexed keywords

CYCLOPENTOLATE;

ADOLESCENT; AMBLYOPIA; ANISOMETROPIA; ARTICLE; ASTIGMATISM; CLINICAL ARTICLE; CONTROLLED STUDY; EYE PROTECTIVE DEVICE; FEMALE; HUMAN; HYPERMETROPIA; MALE; MYOPIA; PATIENT COMPLIANCE; REFRACTION ERROR; SCHOOL CHILD; SPECTACLES; STRABISMUS SURGERY; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

EID: 3242685303     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6700671     Document Type: Article

References (20)

1. von Noorden GK, Campos EC. Examination of the patient-IV amblyopia. In: von Noorden GK, Campos EC (eds). Binocular Vision and Ocular Motility, 6th ed. Mosby: Missouri, 2002, pp 246-287.
2. Levartovsky S, Oliver M, Gottesman N, Shimshoni M. Factors affecting long term results of successfully treated amblyopia: initial visual acuity and type of amblyopia. Br J Ophthalmol 1995; 79: 225-228.
3. Flynn JT, Schiffman J, Feuer W, Corona A. The therapy of amblyopia: an analysis of the results of amblyopia therapy utilizing the pooled data of published studies. Trans Am Ophthalmol Soc 1998; 96: 431-453.
4. Woodruff G, Hiscox F, Thompson JR, Smith LK. Factors affecting the outcome of children treated for amblyopia. Eye 1994; 8 (Part 6): 627-631.
5. Oliver M, Neumann R, Chaimovitch Y, Gottesman N, Shimshoni M. Compliance and results of treatment for amblyopia in children more than 8 years old. Am J Ophthalmol 1986; 102: 340-345.
6. Mintz-Hittner HA, Fernandez KM. Successful amblyopia therapy initiated after age 7 years: compliance cures. Arch Ophthalmol 2000; 118: 1535-1541.
7. Hedgpeth EM, Sullivan M. Anisometropic amblyopia and its treatment. South Med J 1977; 70: 1059-1060.
8. Rutstein RP, Fuhr PS. Efficacy and stability of amblyopia therapy. Optom Vis Sci 1992; 69: 47-54.
9. Epelbaum M, Milleret C, Buisseret P, Dufier JL. The sensitive period for strabismic amblyopia in humans. Ophthalmology 1993; 100: 323-327.
10. Simons K, Stein L, Sener EC, Vitale S, Guyton DL. Full-time atropine, intermittent atropine, and optical penalization and binocular outcome in treatment of strabismic amblyopia. Ophthalmology 1997; 104: 2143-2155.
11. The Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2002; 120: 268-278.
12. Smith LK, Thompson JR, Woodruff G, Hiscox F. Factors affecting treatment compliance in amblyopia. J Pediatr Ophthalmol Strabismus 1995; 32: 98-101.
13. Min BM, Kim SY, Ko KH, Lee SB. A comparison of Min's glasses and conventional occlusion therapy in the treatment of amblyopic children: a prospective study Korean J Ophthalmol 2000; 14: 32-37.
14. Levi DM, Polat U, Hu YS. Improvement in Vernier acuity in adults with amblyopia: practice makes better. Invest Ophthalmol Vis Sci 1997; 38: 1493-1510.
15. El Mallah MK, Chakravarthy U, Hart PM. Amblyopia: is visual loss permanent? Br J Ophthalmol 2000; 84: 952-956.
16. Rabin J. Visual improvement in amblyopia after visual loss in the dominant eye. Am J Optom Physiol Optics 1984; 61: 334-337.
17. Vereecken EP, Brabant P. Prognosis for vision in amblyopia after the loss of the good eye. Arch Ophthalmol 1984; 102: 220-224.
18. Hamed LM, Glaser JS, Schatz NJ. Improvement of vision in the amblyopic eye following visual loss in the contralateral normal eye: a report of three cases. Binoc Vis 1991; 6: 97-100.
19. Lithander J, Sjostrand J. Anisometropic and strabismic amblyopia in the age group 2 years and above: a prospective study of the results of treatment. Br J Ophthalmol 1991; 75: 111-116.
20. Nucci P. Alfarano R, Piantanida A, Brancato R. Compliance in antiamblyopia occlusion therapy. Acta Ophthalmol (Copenh) 1992; 70: 128-131.